Literature DB >> 27275323

Susceptibility of Urinary Tract Bacteria to Newer Antimicrobial Drugs.

Manjula Mehta1, Jyoti Sharma1, Sonia Bhardwaj1.   

Abstract

Urinary tract infections (UTIs) are among the commonest types of bacterial infections. The antibiotic treatment for UTIs is associated with important medical and economic implications. Many different microorganisms can cause UTIs though the most common pathogens are E. coli and members of family Enterobacteriaceae. The knowledge of etiology and antibiotic resistance pattern of the organisms causing urinary tract infection is essential. The present study was undertaken to evaluate trends of antibiotic susceptibility of commonly isolated uropathogens using newer antimicrobial agents, prulifloxacin, fosfomycin (FOM) and doripenem. We conclude that maintaining a record of culture results and the antibiogram may help clinicians to determine the empirical and/or specific treatment based on the antibiogram of the isolate for better therapeutic outcome.

Entities:  

Keywords:  Antibiotic; Urinary tract infection; uropathogens

Year:  2016        PMID: 27275323      PMCID: PMC4884245          DOI: 10.3889/oamjms.2016.020

Source DB:  PubMed          Journal:  Open Access Maced J Med Sci        ISSN: 1857-9655


  15 in total

1.  In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates.

Authors:  M P Montanari; M Mingoia; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

2.  Antimicrobial activity of doripenem against Gram-negative pathogens: results from INVITA-A-DORI Brazilian study.

Authors:  Ana Cristina Gales; Heber D Azevedo; Rosângela Ferraz Cereda; Raquel Girardello; Danilo Elias Xavier
Journal:  Braz J Infect Dis       Date:  2011 Nov-Dec       Impact factor: 1.949

3.  Urinary tract infections in females.

Authors:  C M Kunin
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

4.  Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey.

Authors:  Tulin Demir; Tuncay Buyukguclu
Journal:  Int J Infect Dis       Date:  2013-06-03       Impact factor: 3.623

5.  Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections.

Authors:  G Carmignani; A F De Rose; L Olivieri; E Salvatori; M T Rosignoli; P Dionisio
Journal:  Urol Int       Date:  2005       Impact factor: 2.089

Review 6.  Current concepts in urinary tract infections.

Authors:  D H Williams; A J Schaeffer
Journal:  Minerva Urol Nefrol       Date:  2004-03       Impact factor: 3.720

7.  Doripenem (Doribax)--a new parenteral carbapenem.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  2008-01-28       Impact factor: 1.909

8.  Susceptibility of urinary tract bacteria to fosfomycin.

Authors:  Sofia Maraki; George Samonis; Petros I Rafailidis; Evridiki K Vouloumanou; Emmanuel Mavromanolakis; Matthew E Falagas
Journal:  Antimicrob Agents Chemother       Date:  2009-08-17       Impact factor: 5.191

9.  The mechanism of action of fosfomycin (phosphonomycin).

Authors:  F M Kahan; J S Kahan; P J Cassidy; H Kropp
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

Review 10.  Urinary tract infection: economic considerations.

Authors:  J P Patton; D B Nash; E Abrutyn
Journal:  Med Clin North Am       Date:  1991-03       Impact factor: 5.456

View more
  1 in total

1.  Risk Factors Analysis for Catheter-Associated Urinary Tract Infection in Medan, Indonesia.

Authors:  Hariati Hariati; Dewi Elizadiani Suza; Rosina Tarigan
Journal:  Open Access Maced J Med Sci       Date:  2019-09-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.